9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease

NCT01086553 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

471

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn´s Disease

Interventions

DRUG: budesonide
DRUG: budesonide

Sponsor

Dr. Falk Pharma GmbH